Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESAMOX: Moxifloxacin Triple Therapy for H. pylori Rescue
NCT00455806Phase 3Unknown
- Sponsor
- Technische Universität Dresden
- Start
- Jan 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of moxifloxacin in Helicobacter pylori infection, sponsored by Technische Universität Dresden. Status: unknown.
02
Drugs
moxifloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT00455806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455806.